Cas 460086-74-2,3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid

460086-74-2

Post Buying Request

Basic information

Product Name: 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid
Synonyms: 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid
CAS NO:460086-74-2
Molecular Formula:
Molecular Weight: 445.602
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid(CAS DataBase Reference)
NIST Chemistry Reference: 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid(460086-74-2)
EPA Substance Registry System: 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid(460086-74-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 460086-74-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

460086-74-2 Suppliers

Recommended suppliers

460086-74-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 460086-74-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,0,0,8 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 460086-74:
(8*4)+(7*6)+(6*0)+(5*0)+(4*8)+(3*6)+(2*7)+(1*4)=142
142 % 10 = 2
So 460086-74-2 is a valid CAS Registry Number.

460086-74-2Upstream product

460087-57-4 3-[1-(2-butoxy-3,5-diisopropyl-phenyl)-isoquinolin-7-yl]-but-2(E)-enoic acid methyl ester

460086-74-2Downstream Products

460086-74-2Relevant academic research and scientific papers

Retinoid x receptor modulators

-

, (2008/06/13)

The present invention is directed to compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof: (I). The invention is also directed to pharmaceutical compositions, methods of use and methods of making compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 460086-74-2